Who owns Fulcrum Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of FULC from SEC Form 13F filings across 151 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 151 institutions disclosed 78.4M shares of Fulcrum Therapeutics, Inc. worth $290.2M — about 102.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
151
13F holders
$290.2M
value, 2026 filers
102.8%
of shares outstanding (78.4M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of FULC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.6M | $43.0M | 0.0% | 15.2% | +31.8% |
| 2 | TANG CAPITAL MANAGEMENT LLC | 7.1M | $26.2M | 1.2% | 9.3% | +8.6% |
| 3 | EcoR1 Capital, LLC | 6.8M | $25.2M | 1.1% | 8.9% | +3.9% |
| 4 | ADAR1 Capital Management, LLC | 6.6M | $24.6M | 1.1% | 8.7% | +324.8% |
| 5 | Nantahala Capital Management, LLC | 6.6M | $24.3M | 0.8% | 8.6% | +20.1% |
| 6 | D. E. Shaw & Co., Inc. | 3.7M | $13.7M | 0.0% | 4.9% | +21.8% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | $10.6M | 0.0% | 3.8% | +6.2% |
| 8 | TWO SIGMA INVESTMENTS, LP | 2.6M | $9.6M | 0.0% | 3.4% | +218.8% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 2.2M | $8.2M | 0.0% | 2.9% | +34.7% |
| 10 | MARSHALL WACE, LLP | 1.9M | $7.0M | 0.0% | 2.5% | +39.4% |
| 11 | GSK plc | 1.8M | $6.6M | 1.3% | 2.3% | 0.0% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $6.2M | 0.0% | 2.2% | +16.6% |
| 13 | Qube Research & Technologies Ltd | 1.6M | $5.9M | 0.0% | 2.1% | -8.3% |
| 14 | STATE STREET CORP | 1.3M | $4.7M | 0.0% | 1.7% | -37.3% |
| 15 | BANK OF AMERICA CORP /DE/ | 1.1M | $3.9M | 0.0% | 1.4% | +1.5% |
| 16 | Point72 Asset Management, L.P. | 917,801 | $3.4M | 0.0% | 1.2% | +40.9% |
| 17 | VANGUARD PORTFOLIO MANAGEMENT LLC | 851,198 | $3.1M | 0.0% | 1.1% | +8.8% |
| 18 | Assenagon Asset Management S.A. | 835,204 | $3.1M | 0.0% | 1.1% | 0.0% |
| 19 | Connor, Clark & Lunn Investment Management Ltd. | 762,547 | $2.8M | 0.0% | 1% | +2.3% |
| 20 | GOLDMAN SACHS GROUP INC | 756,644 | $2.8M | 0.0% | 1% | -30.9% |
| 21 | DIMENSIONAL FUND ADVISORS LP | 724,879 | $2.7M | 0.0% | 0.9% | -24.5% |
| 22 | ACADIAN ASSET MANAGEMENT LLC | 701,007 | $2.6M | 0.0% | 0.9% | -32.5% |
| 23 | Alpine Global Management, LLCNEW | 675,000 | $2.5M | 0.5% | 0.9% | new |
| 24 | Balyasny Asset Management L.P. | 671,897 | $2.5M | 0.0% | 0.9% | -3.0% |
| 25 | FMR LLC | 659,776 | $2.4M | 0.0% | 0.9% | +614.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.